SlideShare a Scribd company logo
1 of 43
Antimicrobial Drug
PENICILLINS
• Penicillin was the first antibiotic to be used clinically in 1941.
• The penicillin nucleus consists of fused thiazolidine and β-lactam rings
to which side chains are attached through an amide linkage.
• Sources: It was originally obtained from the fungus Penicillium
notatum.
• Mechanism of action:All β-lactam antibiotics interfere with the
synthesis of bacterial cell wall
Classification of Penicillin
1. Natural penicillin: PENICILLIN-G (BENZYL PENICILLIN)
2. SEMISYNTHETIC PENICILLINS:
1. Acid-resistant alternative to penicillin G
Phenoxymethyl penicillin (Penicillin V).
2. Penicillinase-resistant penicillins
Methicillin, Cloxacillin, Dicloxacillin.
3. Extended spectrum penicillins
(a) Aminopenicillins: Ampicillin, Bacampicillin, Amoxicillin.
(b) Carboxypenicillins: Carbenicillin.
(c) Ureidopenicillins: Piperacillin, Mezlocillin
PENICILLIN-G (BENZYL PENICILLIN)
It is a narrow spectrum antibiotic; activity is limited primarily to gram-
positive bacteria, few gram negative ones and anaerobes.
Pharmacokinetics:
Penicillin G is acid labile, therefore destroyed by gastric acid. As such, less
than 1/3rd of an oral dose is absorbed in the active form. Absorption of sod.
PnG from i.m. site is rapid and complete; peak plasma level is attained in 30
min. The pharmacokinetics of PnG is dominated by very rapid renal
excretion; about 10% by glomerular filtration and the rest by tubular
secretion.
Adverse effects:
Local irritancy and direct toxicity
Hypersensitivity
Indication
• Streptococcal infections
• Pneumococcal infections
• Meningococcal infections
• Gonorrhoea
• Syphilis
• Diphtheria
Contraindication:
It is contraindicated in a patients who have a previous history of severe
allergic reactions or penicillin and its derivatives.
Penicillin is also contraindicated in patients who have had Stevens-Johnson
syndrome after administering penicillin or a penicillin derivative.
CEPHALOSPORINS
• These are a group of semisynthetic antibiotics obtained from a fungus
Cephalosporium. They are chemically related to penicillins; the
nucleus consists of a β-lactam ring fused to a dihydrothiazine ring.
• All cephalosporins are bactericidal and have the same mechanism of
action as penicillin.
Pharmacokinetics
 Rout of administration:
 Oral
 Parenteral
 Distribution
 Body fluid
 Joint fluid
 Pleural fluid
 CNS
 Elimination
 Unchanged in urine
 Renal tubules
 Plasma Half-life: 1-4 hours mostly
Adverse Drug Reaction
 Allergic reaction
 Anaphaylaxis
 Serum sickness
 Urticaria
 Skin rash
 Haemolytic anaemia etc..
 GIT upset
 Nausia
 Vomiting
 Diarrhoea
 Nephrotoxicity:
 Interstitial Nephritis
 Renal Tubular necrosis
 Others:
 Disulfiram-like reaction
 Local irritation after I/M injection
 Thromboflavitis after repeated I/V
 Bleeding tendency
 Eosinophilia and thrombocytosis
 Defect of newborn babies
 Pharyngitis ( Throat infection)
 Stillbirth or Miscarriage
Indication
• UTI
• Infection of gut
• Respiratory tract infection
• Boils, abscess
• Prophylaxis in surgery
• Biliary sepsis
• Person allergic to penicillin
• Meningitis
• Gonorrhoea
• Infected burns
Contraindication
 These drugs are contraindicated in patient with known
hypersensitivity to cephalosporin & penicillin
• .
Renal failure
Hepatic impairment
Rheumatic fever
Lactating patient and anaerobic infections.
Pregnancy & Breastfeeding
Sulfonamides
⚫AKA “sulfadrugs”
⚫Effectiveagainsta broad rangeof microorganisms
⚫Block specific step in biosynthetic pathwayof folic
acid
⚫Interferewith PABAand folicacid formation, thereby
destroying bacteria
Sulfonamides
Pharmacokinetics
• A – Rapidly and well absorbed orally
• D - Widely distributed in the body
- Crosses BBB and placenta
- Accumulates in prostatic fluid
- Extent of plasma protein binding differs  Longer acting agents are highly protein
bound
• M – Acetylation in the Liver  acetylated metabolites are inactive
• E – Kidney by glomerular filtration
Indication
• UTI
• Ulcerative colitis
• Respiratory tract infections
• Burns and skin diseases
• Meningococcal meningitis
Contraindication:
The sulphonamides are contraindicated in patients with a history of
sulpha hypersensitivity and advance kidney disease
Adverse effects:
⚫Rash
⚫Nausea
⚫Drug fever
⚫Vomiting
⚫Jaundice
⚫Blood complications
⚫Kidneydamage
• Sulfamethoxazole + Trimethoprim
• This combination is BACTERICIDAL
(Both drugs are bacteriostatic when given alone)
Cotrimoxazole
Trimethoprim vs. Sulfamethoxazole
(Cotrimoxazole)
TRIMETHOPRIM SULFAMETHOXAZOLE
• Diaminopyrimadine related to antimalarial drug • Intermediate acting PABAstructural analogue
PYRIMETHAMINE
• MOA: Inhibits bacterial dihydrofolate • MOA: Inhibits folate synthase
reductase (DHFRase)
• Bacteriostatic • Bacteriostatic
Combination is BACTERICIDAL against many organisms
• Pharmacokinetics:
A – More rapidly absorbed
D – 40% plasma protein bound
M – Partly metabolized in Liver
E – Excreted in urine
• Pharmacokinetics:
A – Rapidly absorbed
D – 65% plasma protein bound
M – Acetylation in Liver
E – Renal excretion by glomerular filtration
• Both compounds have a similar half life (~10 hours)
• Two bacteriostatic drugs produces bactericidal action when combined
• The combination has a wider antibacterial spectrum
• The combination delays the development of bacterial resistance
• The MIC of each component can be reduced 3-6 times
• Trimethoprim enters many tissues and has a larger volume of distribution
Uses
(Cotrimoxazole)
*Cotrimoxazole is still used now… however, its popularity has decreased in the treatment
of systemic infections
1. Urinary Tract Infections
2. Respiratory Tract Infections
3. Bacterial Diarrheas + Dysentery
4. Pneumocystis jiroveci (Pneumonia in Neutropenic/AIDS patient)
5. Sexually transmitted Diseases
6. Typhoid
Adverse Effects
(Cotrimoxzole)
• All the adverse effects seen with Sulfonamides can be seen with Cotrimoxazole
• Nausea, Vomiting, Headache, Stomatitis
• Rashes
• Folate deficiency ONLY in patients with marginal folate levels
• Blood dyscrasias (RARE)
Contraindications
(Cotrimoxazole)
• AVOID IN PREGNANCY
• Trimethoprim is an antifolate  Theoretical teratogenic risk
• Uremia in renal disease
• Greater risk of bone marrow toxicity in the elderly
• Fever, Rash and bone marrow hypoplasia among AIDS patients with P. jiroveci infection
Macrolides
• The macrolide antibiotics structurally consist of a large lactone ring to
which sugars are attached. They include
• Erythromycin
• Azithromycin
• Clarithromycin
• Spiramycin
Mechanism of Action
• Bacteriostatic- usually
• Inhibit bacterial RNA-dependent protein synthesis
• Bound to the 50S ribosomal subunits and blocks the
execution of instruction coded by mRNA.
Pharmacokinetics
• Absorption (Oral)
• Erythromycin: variable absorption of 15% - 45%
• Clarithromycin: 55%
• Azithromycin: 38%
• Half Life (T1/2)
• Erythromycin 1.4 Hours
• Clarithromycin (250mg and 500mg 12hrly) 3-4 & 5-7 hours respectively
• Azithromycin 68hours
• Excellent tissue and intracellular concentrations
• Tissue levels can be 10-100 times higher than those in serum
• Poor penetration into brain and CSF
• Cross the placenta and excreted in breast milk
Metabolism & Elimination
• ALL hepatic elimination
Indications
• First line choice as an alternative to penicillin in the penicillin-
sensitive patients (example gonorrhoea, syphilis, streptococcal and
pneumococcal infections, rheumatic fever prophylaxis), alternative to
a tetracycline in mycoplasma pneumoniae infection, pertussis
(whooping cough), diphtheria.
• Second line choice in bronchitis and penicillin-resistant staphylococcal
infections.
Adverse Effects
• Gastrointestinal (up to 33 %) (especially Erythromycin)
• Nausea
• Vomiting
• Diarrhoea
• Dyspepsia
• Thrombophlebitis: IV Erythromycin & Azithromycin
• Other: ototoxicity with high dose erythromycin in renal impairment
Tetracyclines
• The first member of this family was chlortetracycline, derived from
the soil organism Streptomyces aureofaciens. This was followed by
oxytetracycline produced from Streptomyces rimosus. The
tetracyclines available for the clinical use are:
Doxycycline
Oxytetracycline
Minocycline
Demeclocycline
Mechanism of action
• It enter bacterial cells by either passive diffusion through pores on by
an active transport system. Inside the bacterial cells, they bind
specifically to 30S ribosomes, thereby blocking binding of transfer
RNA to the messenger RNA-ribosome complex, inhibiting protein
synthesis.
Pharmacokinetic
• Incompletely absorbed from GI, improved by fasting
• Metabolised by the liver and concentrated in bile (3-5X higher than
serum levels)
• Excretion primarily in the urine except doxycycline ( 60% biliary tract
into faeces,40% in urine)
Indications
Tetracyclines are the first choice drugs for:
• Chronic bronchitis
• Non specific urethritis
• Primarily atypical pneumonia
• Rickettsia infections
• Pustular acne
• Cholera
Second line choice for:
• Syphilis (in penicillin allergic patients it is first choice)
• Meningococcal carriers
Contraindications
• They are usually contraindicated in pregnancy, lactation, peptic ulcer
and hepatic disease.
Adverse effects:
Gastrointestinal upset: Anorexia, heartburn, nausea, vomiting
Organ toxicity: Liver damage, Kidney damage
Phototoxicity
Brown staining of teeth
Fluoroquinolones
• Nalidixic acid, 4-quinolone, and other related compounds exert
antimicrobial action by inhibiting DNA synthesis.
• Currently the Fluoroquinolones:
• Cinoxacin
• Enoxacin
• Norfloxacin
• Ciprofloxacin
• Levofloxacin
• Lomefloxacin
• Ofloxacin
• Pefloxacin
Pharmacokinetics
• Absorption
• Good bioavailability
• Oral bioavailability 60-95%
• Divalent and trivalent cations (Zinc, Iron, Calcium, Aluminum, Magnesium) and antacids
reduce GI absorption
• Distribution
• Extensive tissue distribution but poor CSF penetration
• Metabolism and Elimination
• Combination of renal and hepatic routes
Indications
• The fluoroquinolones are indicated for treatment of several bacterial
infections, including bacterial bronchitis, pneumonia, sinusitis, urinary
tract infections, septicemia and intraabdominal infections, joint and
bone infections, soft tissue and skin infections, typhoid fever, anthrax,
bacterial gastroenteritis, urethral and gynecological infections, and
pelvic inflammatory disease and several other infectious conditions.
Contraindications
• There is no absolute contraindication but a caution must be observed in
young children and in pregnant or nursing mothers.
Adverse Reactions:
• Nausea, headache, dizziness, abdominal discomfort, photosensitivity and
skin rash
• Palpitation, hypertension and angina
• Pain, burning, tingling, numbness, weakness
• nerve damage in hands, feet, arms, or legs
• Depression, anxiety or other changes in mental health
Aminoglycosides
• The aminoglycosides are so named because they are composed of
amino sugars connected by glycosidic linkages
Naturally occurring:
•Streptomycin
•Neomycin
•Kanamycin
•Tobramycin
•Gentamicin
Semisynthetic derivatives:
•Amikacin (from Kanamycin)
•Netilmicin (from Sisomicin)
Mechanism of action
• Inhibit bacterial protein synthesis by irreversibly binding to 30S
ribosomal unit and distort the mRNA translation of the genetic code,
thereby preventing the formation of normal complex required to
initiate protein synthesis.
Pharmacokinetics
They are poorly absorbed following oral administration thus
given by injection to treat systemic infection.
• Distribution: It is widely distributes into body fluids but very poorly into;
• CSF
• Vitreous fluid of the eye
• Biliary tract
• Prostate
• Tracheobronchial secretions
• Adipose tissue
• Elimination
• 85-95% eliminated unchanged via kidney
• t1/2 dependent on renal function
• In normal renal function t1/2 is 2-3 hours
Indications
• severe infections of the abdomen and urinary tract, as well as
bacteremia and endocarditis.
Contraindication: it should be avoided in pregnancy as it crosses
the placenta
Adverse Effects
• Nephrotoxicity
• Direct proximal tubular damage - reversible if caught early
• Ototoxicity
• 8th cranial nerve damage – irreversible vestibular and auditory
toxicity
• Neuromuscular paralysis
• Can occur after rapid IV infusion especially with;

More Related Content

Similar to antimicrobial.pptx

Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study martinshaji
 
Pharmacology of Sulfonamides
Pharmacology of Sulfonamides  Pharmacology of Sulfonamides
Pharmacology of Sulfonamides paramesh Researcher
 
Antifungals
AntifungalsAntifungals
Antifungalsmzabihi
 
Macrolides antibiotics (with lincosamide)
Macrolides antibiotics (with lincosamide) Macrolides antibiotics (with lincosamide)
Macrolides antibiotics (with lincosamide) Dr. Rupendra Bharti
 
antituberculardrugs-150922084323-lva1-app6892.pdf
antituberculardrugs-150922084323-lva1-app6892.pdfantituberculardrugs-150922084323-lva1-app6892.pdf
antituberculardrugs-150922084323-lva1-app6892.pdfLahariNaidu7
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugsDr. Pramod B
 
Antibiotics in pneumonia.pptx
Antibiotics in pneumonia.pptxAntibiotics in pneumonia.pptx
Antibiotics in pneumonia.pptxShrutkirtigupta1
 
Cephalosporin.pptx
Cephalosporin.pptxCephalosporin.pptx
Cephalosporin.pptxmdtaieb1
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistrySushant Pandey
 
Systemic antibiotics in endodontics
Systemic antibiotics in endodonticsSystemic antibiotics in endodontics
Systemic antibiotics in endodonticsMohamedElsayed691
 
4 introduction to antimicrobials
4  introduction to antimicrobials4  introduction to antimicrobials
4 introduction to antimicrobialsIAU Dent
 
Antibiotic Tetracyclines history,classification,mechanism of action and adver...
Antibiotic Tetracyclines history,classification,mechanism of action and adver...Antibiotic Tetracyclines history,classification,mechanism of action and adver...
Antibiotic Tetracyclines history,classification,mechanism of action and adver...Muhammad Amir Sohail
 

Similar to antimicrobial.pptx (20)

Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study
 
Protein synthesis inhibitors
Protein synthesis inhibitorsProtein synthesis inhibitors
Protein synthesis inhibitors
 
Macrolide antibiotics.pptx
Macrolide antibiotics.pptxMacrolide antibiotics.pptx
Macrolide antibiotics.pptx
 
Pharmacology of Sulfonamides
Pharmacology of Sulfonamides  Pharmacology of Sulfonamides
Pharmacology of Sulfonamides
 
Antifungals
AntifungalsAntifungals
Antifungals
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Macrolides antibiotics (with lincosamide)
Macrolides antibiotics (with lincosamide) Macrolides antibiotics (with lincosamide)
Macrolides antibiotics (with lincosamide)
 
antituberculardrugs-150922084323-lva1-app6892.pdf
antituberculardrugs-150922084323-lva1-app6892.pdfantituberculardrugs-150922084323-lva1-app6892.pdf
antituberculardrugs-150922084323-lva1-app6892.pdf
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
 
Antibiotics in pneumonia.pptx
Antibiotics in pneumonia.pptxAntibiotics in pneumonia.pptx
Antibiotics in pneumonia.pptx
 
Ab
AbAb
Ab
 
Cephalosporin.pptx
Cephalosporin.pptxCephalosporin.pptx
Cephalosporin.pptx
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistry
 
Anti TBs.pptx
Anti TBs.pptxAnti TBs.pptx
Anti TBs.pptx
 
Sulfonamides
SulfonamidesSulfonamides
Sulfonamides
 
Systemic antibiotics in endodontics
Systemic antibiotics in endodonticsSystemic antibiotics in endodontics
Systemic antibiotics in endodontics
 
4 introduction to antimicrobials
4  introduction to antimicrobials4  introduction to antimicrobials
4 introduction to antimicrobials
 
Antibiotic Tetracyclines history,classification,mechanism of action and adver...
Antibiotic Tetracyclines history,classification,mechanism of action and adver...Antibiotic Tetracyclines history,classification,mechanism of action and adver...
Antibiotic Tetracyclines history,classification,mechanism of action and adver...
 
Antimicrobials 1
Antimicrobials 1Antimicrobials 1
Antimicrobials 1
 
Antibiotics 2015 in icu
Antibiotics 2015 in icuAntibiotics 2015 in icu
Antibiotics 2015 in icu
 

More from RashmiShah46

Antiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptAntiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptRashmiShah46
 
Antiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptAntiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptRashmiShah46
 
ppe-160326114551.pptx
ppe-160326114551.pptxppe-160326114551.pptx
ppe-160326114551.pptxRashmiShah46
 
Antifungal drugs.pptx
Antifungal drugs.pptxAntifungal drugs.pptx
Antifungal drugs.pptxRashmiShah46
 
Antiamoebic drugs classification.pptx
Antiamoebic drugs                  classification.pptxAntiamoebic drugs                  classification.pptx
Antiamoebic drugs classification.pptxRashmiShah46
 
Drugs for peptic ulcer - Copy.pptx
Drugs for peptic ulcer - Copy.pptxDrugs for peptic ulcer - Copy.pptx
Drugs for peptic ulcer - Copy.pptxRashmiShah46
 
nsaidsnew-180525171456 (1).pptx
nsaidsnew-180525171456 (1).pptxnsaidsnew-180525171456 (1).pptx
nsaidsnew-180525171456 (1).pptxRashmiShah46
 
cephalosporin-180714171228.pptx
cephalosporin-180714171228.pptxcephalosporin-180714171228.pptx
cephalosporin-180714171228.pptxRashmiShah46
 
Antibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptAntibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptRashmiShah46
 
druginteractions-130719120045-phpapp02.pptx
druginteractions-130719120045-phpapp02.pptxdruginteractions-130719120045-phpapp02.pptx
druginteractions-130719120045-phpapp02.pptxRashmiShah46
 
HOMEOSTASIS.pptx
HOMEOSTASIS.pptxHOMEOSTASIS.pptx
HOMEOSTASIS.pptxRashmiShah46
 
unit1_general introduction_pharmacology.pptx
unit1_general introduction_pharmacology.pptxunit1_general introduction_pharmacology.pptx
unit1_general introduction_pharmacology.pptxRashmiShah46
 

More from RashmiShah46 (15)

Antiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptAntiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.ppt
 
Antiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.pptAntiparkinsonian drugs_Adarsh.ppt
Antiparkinsonian drugs_Adarsh.ppt
 
ppe-160326114551.pptx
ppe-160326114551.pptxppe-160326114551.pptx
ppe-160326114551.pptx
 
ADR.pptx
ADR.pptxADR.pptx
ADR.pptx
 
Antifungal drugs.pptx
Antifungal drugs.pptxAntifungal drugs.pptx
Antifungal drugs.pptx
 
Antiamoebic drugs classification.pptx
Antiamoebic drugs                  classification.pptxAntiamoebic drugs                  classification.pptx
Antiamoebic drugs classification.pptx
 
Drugs for peptic ulcer - Copy.pptx
Drugs for peptic ulcer - Copy.pptxDrugs for peptic ulcer - Copy.pptx
Drugs for peptic ulcer - Copy.pptx
 
nsaidsnew-180525171456 (1).pptx
nsaidsnew-180525171456 (1).pptxnsaidsnew-180525171456 (1).pptx
nsaidsnew-180525171456 (1).pptx
 
cephalosporin-180714171228.pptx
cephalosporin-180714171228.pptxcephalosporin-180714171228.pptx
cephalosporin-180714171228.pptx
 
Antibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptAntibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.ppt
 
druginteractions-130719120045-phpapp02.pptx
druginteractions-130719120045-phpapp02.pptxdruginteractions-130719120045-phpapp02.pptx
druginteractions-130719120045-phpapp02.pptx
 
18.ppt
18.ppt18.ppt
18.ppt
 
HOMEOSTASIS.pptx
HOMEOSTASIS.pptxHOMEOSTASIS.pptx
HOMEOSTASIS.pptx
 
unit1_general introduction_pharmacology.pptx
unit1_general introduction_pharmacology.pptxunit1_general introduction_pharmacology.pptx
unit1_general introduction_pharmacology.pptx
 
23.pdf
23.pdf23.pdf
23.pdf
 

Recently uploaded

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Recently uploaded (20)

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

antimicrobial.pptx

  • 2. PENICILLINS • Penicillin was the first antibiotic to be used clinically in 1941. • The penicillin nucleus consists of fused thiazolidine and β-lactam rings to which side chains are attached through an amide linkage. • Sources: It was originally obtained from the fungus Penicillium notatum. • Mechanism of action:All β-lactam antibiotics interfere with the synthesis of bacterial cell wall
  • 3. Classification of Penicillin 1. Natural penicillin: PENICILLIN-G (BENZYL PENICILLIN) 2. SEMISYNTHETIC PENICILLINS: 1. Acid-resistant alternative to penicillin G Phenoxymethyl penicillin (Penicillin V). 2. Penicillinase-resistant penicillins Methicillin, Cloxacillin, Dicloxacillin. 3. Extended spectrum penicillins (a) Aminopenicillins: Ampicillin, Bacampicillin, Amoxicillin. (b) Carboxypenicillins: Carbenicillin. (c) Ureidopenicillins: Piperacillin, Mezlocillin
  • 4. PENICILLIN-G (BENZYL PENICILLIN) It is a narrow spectrum antibiotic; activity is limited primarily to gram- positive bacteria, few gram negative ones and anaerobes. Pharmacokinetics: Penicillin G is acid labile, therefore destroyed by gastric acid. As such, less than 1/3rd of an oral dose is absorbed in the active form. Absorption of sod. PnG from i.m. site is rapid and complete; peak plasma level is attained in 30 min. The pharmacokinetics of PnG is dominated by very rapid renal excretion; about 10% by glomerular filtration and the rest by tubular secretion. Adverse effects: Local irritancy and direct toxicity Hypersensitivity
  • 5. Indication • Streptococcal infections • Pneumococcal infections • Meningococcal infections • Gonorrhoea • Syphilis • Diphtheria Contraindication: It is contraindicated in a patients who have a previous history of severe allergic reactions or penicillin and its derivatives. Penicillin is also contraindicated in patients who have had Stevens-Johnson syndrome after administering penicillin or a penicillin derivative.
  • 6. CEPHALOSPORINS • These are a group of semisynthetic antibiotics obtained from a fungus Cephalosporium. They are chemically related to penicillins; the nucleus consists of a β-lactam ring fused to a dihydrothiazine ring. • All cephalosporins are bactericidal and have the same mechanism of action as penicillin.
  • 7.
  • 8. Pharmacokinetics  Rout of administration:  Oral  Parenteral  Distribution  Body fluid  Joint fluid  Pleural fluid  CNS  Elimination  Unchanged in urine  Renal tubules  Plasma Half-life: 1-4 hours mostly
  • 9. Adverse Drug Reaction  Allergic reaction  Anaphaylaxis  Serum sickness  Urticaria  Skin rash  Haemolytic anaemia etc..  GIT upset  Nausia  Vomiting  Diarrhoea  Nephrotoxicity:  Interstitial Nephritis  Renal Tubular necrosis  Others:  Disulfiram-like reaction  Local irritation after I/M injection  Thromboflavitis after repeated I/V  Bleeding tendency  Eosinophilia and thrombocytosis  Defect of newborn babies  Pharyngitis ( Throat infection)  Stillbirth or Miscarriage
  • 10. Indication • UTI • Infection of gut • Respiratory tract infection • Boils, abscess • Prophylaxis in surgery • Biliary sepsis • Person allergic to penicillin • Meningitis • Gonorrhoea • Infected burns
  • 11. Contraindication  These drugs are contraindicated in patient with known hypersensitivity to cephalosporin & penicillin • . Renal failure Hepatic impairment Rheumatic fever Lactating patient and anaerobic infections. Pregnancy & Breastfeeding
  • 12. Sulfonamides ⚫AKA “sulfadrugs” ⚫Effectiveagainsta broad rangeof microorganisms ⚫Block specific step in biosynthetic pathwayof folic acid ⚫Interferewith PABAand folicacid formation, thereby destroying bacteria
  • 14.
  • 15.
  • 16. Pharmacokinetics • A – Rapidly and well absorbed orally • D - Widely distributed in the body - Crosses BBB and placenta - Accumulates in prostatic fluid - Extent of plasma protein binding differs  Longer acting agents are highly protein bound • M – Acetylation in the Liver  acetylated metabolites are inactive • E – Kidney by glomerular filtration
  • 17. Indication • UTI • Ulcerative colitis • Respiratory tract infections • Burns and skin diseases • Meningococcal meningitis Contraindication: The sulphonamides are contraindicated in patients with a history of sulpha hypersensitivity and advance kidney disease Adverse effects: ⚫Rash ⚫Nausea ⚫Drug fever ⚫Vomiting ⚫Jaundice ⚫Blood complications ⚫Kidneydamage
  • 18. • Sulfamethoxazole + Trimethoprim • This combination is BACTERICIDAL (Both drugs are bacteriostatic when given alone) Cotrimoxazole
  • 19. Trimethoprim vs. Sulfamethoxazole (Cotrimoxazole) TRIMETHOPRIM SULFAMETHOXAZOLE • Diaminopyrimadine related to antimalarial drug • Intermediate acting PABAstructural analogue PYRIMETHAMINE • MOA: Inhibits bacterial dihydrofolate • MOA: Inhibits folate synthase reductase (DHFRase) • Bacteriostatic • Bacteriostatic Combination is BACTERICIDAL against many organisms • Pharmacokinetics: A – More rapidly absorbed D – 40% plasma protein bound M – Partly metabolized in Liver E – Excreted in urine • Pharmacokinetics: A – Rapidly absorbed D – 65% plasma protein bound M – Acetylation in Liver E – Renal excretion by glomerular filtration
  • 20. • Both compounds have a similar half life (~10 hours) • Two bacteriostatic drugs produces bactericidal action when combined • The combination has a wider antibacterial spectrum • The combination delays the development of bacterial resistance • The MIC of each component can be reduced 3-6 times • Trimethoprim enters many tissues and has a larger volume of distribution
  • 21.
  • 22. Uses (Cotrimoxazole) *Cotrimoxazole is still used now… however, its popularity has decreased in the treatment of systemic infections 1. Urinary Tract Infections 2. Respiratory Tract Infections 3. Bacterial Diarrheas + Dysentery 4. Pneumocystis jiroveci (Pneumonia in Neutropenic/AIDS patient) 5. Sexually transmitted Diseases 6. Typhoid
  • 23. Adverse Effects (Cotrimoxzole) • All the adverse effects seen with Sulfonamides can be seen with Cotrimoxazole • Nausea, Vomiting, Headache, Stomatitis • Rashes • Folate deficiency ONLY in patients with marginal folate levels • Blood dyscrasias (RARE)
  • 24. Contraindications (Cotrimoxazole) • AVOID IN PREGNANCY • Trimethoprim is an antifolate  Theoretical teratogenic risk • Uremia in renal disease • Greater risk of bone marrow toxicity in the elderly • Fever, Rash and bone marrow hypoplasia among AIDS patients with P. jiroveci infection
  • 25. Macrolides • The macrolide antibiotics structurally consist of a large lactone ring to which sugars are attached. They include • Erythromycin • Azithromycin • Clarithromycin • Spiramycin
  • 26. Mechanism of Action • Bacteriostatic- usually • Inhibit bacterial RNA-dependent protein synthesis • Bound to the 50S ribosomal subunits and blocks the execution of instruction coded by mRNA.
  • 27. Pharmacokinetics • Absorption (Oral) • Erythromycin: variable absorption of 15% - 45% • Clarithromycin: 55% • Azithromycin: 38% • Half Life (T1/2) • Erythromycin 1.4 Hours • Clarithromycin (250mg and 500mg 12hrly) 3-4 & 5-7 hours respectively • Azithromycin 68hours • Excellent tissue and intracellular concentrations • Tissue levels can be 10-100 times higher than those in serum • Poor penetration into brain and CSF • Cross the placenta and excreted in breast milk Metabolism & Elimination • ALL hepatic elimination
  • 28. Indications • First line choice as an alternative to penicillin in the penicillin- sensitive patients (example gonorrhoea, syphilis, streptococcal and pneumococcal infections, rheumatic fever prophylaxis), alternative to a tetracycline in mycoplasma pneumoniae infection, pertussis (whooping cough), diphtheria. • Second line choice in bronchitis and penicillin-resistant staphylococcal infections.
  • 29. Adverse Effects • Gastrointestinal (up to 33 %) (especially Erythromycin) • Nausea • Vomiting • Diarrhoea • Dyspepsia • Thrombophlebitis: IV Erythromycin & Azithromycin • Other: ototoxicity with high dose erythromycin in renal impairment
  • 30. Tetracyclines • The first member of this family was chlortetracycline, derived from the soil organism Streptomyces aureofaciens. This was followed by oxytetracycline produced from Streptomyces rimosus. The tetracyclines available for the clinical use are: Doxycycline Oxytetracycline Minocycline Demeclocycline
  • 31. Mechanism of action • It enter bacterial cells by either passive diffusion through pores on by an active transport system. Inside the bacterial cells, they bind specifically to 30S ribosomes, thereby blocking binding of transfer RNA to the messenger RNA-ribosome complex, inhibiting protein synthesis.
  • 32. Pharmacokinetic • Incompletely absorbed from GI, improved by fasting • Metabolised by the liver and concentrated in bile (3-5X higher than serum levels) • Excretion primarily in the urine except doxycycline ( 60% biliary tract into faeces,40% in urine)
  • 33. Indications Tetracyclines are the first choice drugs for: • Chronic bronchitis • Non specific urethritis • Primarily atypical pneumonia • Rickettsia infections • Pustular acne • Cholera Second line choice for: • Syphilis (in penicillin allergic patients it is first choice) • Meningococcal carriers
  • 34. Contraindications • They are usually contraindicated in pregnancy, lactation, peptic ulcer and hepatic disease. Adverse effects: Gastrointestinal upset: Anorexia, heartburn, nausea, vomiting Organ toxicity: Liver damage, Kidney damage Phototoxicity Brown staining of teeth
  • 35. Fluoroquinolones • Nalidixic acid, 4-quinolone, and other related compounds exert antimicrobial action by inhibiting DNA synthesis. • Currently the Fluoroquinolones: • Cinoxacin • Enoxacin • Norfloxacin • Ciprofloxacin • Levofloxacin • Lomefloxacin • Ofloxacin • Pefloxacin
  • 36. Pharmacokinetics • Absorption • Good bioavailability • Oral bioavailability 60-95% • Divalent and trivalent cations (Zinc, Iron, Calcium, Aluminum, Magnesium) and antacids reduce GI absorption • Distribution • Extensive tissue distribution but poor CSF penetration • Metabolism and Elimination • Combination of renal and hepatic routes
  • 37. Indications • The fluoroquinolones are indicated for treatment of several bacterial infections, including bacterial bronchitis, pneumonia, sinusitis, urinary tract infections, septicemia and intraabdominal infections, joint and bone infections, soft tissue and skin infections, typhoid fever, anthrax, bacterial gastroenteritis, urethral and gynecological infections, and pelvic inflammatory disease and several other infectious conditions.
  • 38. Contraindications • There is no absolute contraindication but a caution must be observed in young children and in pregnant or nursing mothers. Adverse Reactions: • Nausea, headache, dizziness, abdominal discomfort, photosensitivity and skin rash • Palpitation, hypertension and angina • Pain, burning, tingling, numbness, weakness • nerve damage in hands, feet, arms, or legs • Depression, anxiety or other changes in mental health
  • 39. Aminoglycosides • The aminoglycosides are so named because they are composed of amino sugars connected by glycosidic linkages Naturally occurring: •Streptomycin •Neomycin •Kanamycin •Tobramycin •Gentamicin Semisynthetic derivatives: •Amikacin (from Kanamycin) •Netilmicin (from Sisomicin)
  • 40. Mechanism of action • Inhibit bacterial protein synthesis by irreversibly binding to 30S ribosomal unit and distort the mRNA translation of the genetic code, thereby preventing the formation of normal complex required to initiate protein synthesis.
  • 41. Pharmacokinetics They are poorly absorbed following oral administration thus given by injection to treat systemic infection. • Distribution: It is widely distributes into body fluids but very poorly into; • CSF • Vitreous fluid of the eye • Biliary tract • Prostate • Tracheobronchial secretions • Adipose tissue • Elimination • 85-95% eliminated unchanged via kidney • t1/2 dependent on renal function • In normal renal function t1/2 is 2-3 hours
  • 42. Indications • severe infections of the abdomen and urinary tract, as well as bacteremia and endocarditis. Contraindication: it should be avoided in pregnancy as it crosses the placenta
  • 43. Adverse Effects • Nephrotoxicity • Direct proximal tubular damage - reversible if caught early • Ototoxicity • 8th cranial nerve damage – irreversible vestibular and auditory toxicity • Neuromuscular paralysis • Can occur after rapid IV infusion especially with;